(MPW) Medical Properties Trust - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58463J3041
MPW: Hospitals, Healthcare, Real Estate, Facilities, Beds
Medical Properties Trust, Inc. (NYSE: MPW) stands as a prominent figure in the healthcare real estate sector, established in 2003. The companys ascent from its origins in Birmingham, Alabama, to becoming a global leader with 441 facilities and around 44,000 licensed beds as of September 2023 underscores its strategic prowess. Following the third quarter, the divestiture of four facilities adjusted their holdings to approximately 43,000 beds across nine countries and three continents.
MPWs business model is rooted in acquiring and leasing hospital facilities through net leases, ensuring a steady cash flow. This approach empowers hospital operators to monetize their real estate, channeling funds into critical areas like infrastructure, technology, and operational enhancements. Their role extends beyond mere real estate investment, positioning them as strategic partners in healthcare delivery.
Financially, MPW boasts a market capitalization of $2.97 billion, with a forward P/E of 6.67 and a price-to-book ratio of 0.53. These metrics highlight its attractive valuation. The companys focus on high-quality, income-generating assets underpins its investment appeal, offering a stable revenue stream through long-term leases, typically spanning 15 to 20 years.
Investors are drawn to MPWs resilience; healthcare infrastructure demand remains robust, shielded from economic fluctuations. The companys global diversification across the U.S., Europe, and Australia mitigates regional risks. Managements deep sector expertise further enhances their ability to navigate the complex healthcare landscape, ensuring alignment with operators needs and fostering mutually beneficial partnerships.
MPWs strategic initiatives, including selective acquisitions and portfolio optimization, reinforce their position as a leading healthcare REIT. Their commitment to sustainable growth and strong governance practices underscores their reliability as an investment avenue in the healthcare real estate sector.
Additional Sources for MPW Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MPW Stock Overview
Market Cap in USD | 3,628m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 2005-07-08 |
MPW Stock Ratings
Growth 5y | -43.0% |
Fundamental | -30.7% |
Dividend | 36.2% |
Rel. Strength | 34.8 |
Analysts | 2.67/5 |
Fair Price Momentum | 6.23 USD |
Fair Price DCF | 1.92 USD |
MPW Dividends
Dividend Yield 12m | 10.32% |
Yield on Cost 5y | 5.03% |
Annual Growth 5y | -15.69% |
Payout Consistency | 93.8% |
MPW Growth Ratios
Growth Correlation 3m | 96.4% |
Growth Correlation 12m | 24.3% |
Growth Correlation 5y | -80.8% |
CAGR 5y | -11.25% |
CAGR/Max DD 5y | -0.13 |
Sharpe Ratio 12m | -0.81 |
Alpha | 42.75 |
Beta | 1.365 |
Volatility | 41.13% |
Current Volume | 5013.8k |
Average Volume 20d | 9112.6k |
As of April 03, 2025, the stock is trading at USD 5.91 with a total of 5,013,784 shares traded.
Over the past week, the price has changed by -3.59%, over one month by +3.63%, over three months by +48.99% and over the past year by +52.80%.
Probably not. Based on ValueRay Fundamental Analyses, Medical Properties Trust (NYSE:MPW) is currently (April 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -30.74 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MPW as of April 2025 is 6.23. This means that MPW is currently overvalued and has a potential downside of 5.41%.
Medical Properties Trust has received a consensus analysts rating of 2.67. Therefor, it is recommend to hold MPW.
- Strong Buy: 0
- Buy: 1
- Hold: 7
- Sell: 3
- Strong Sell: 1
According to ValueRays Forecast Model, MPW Medical Properties Trust will be worth about 6.7 in April 2026. The stock is currently trading at 5.91. This means that the stock has a potential upside of +13.87%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 5.5 | -6.9% |
Analysts Target Price | 4.6 | -22.8% |
ValueRay Target Price | 6.7 | 13.9% |